Asian Phytoceuticals PCL
SET:APCO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.82
8.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Asian Phytoceuticals PCL
Capital Expenditures
Asian Phytoceuticals PCL
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Asian Phytoceuticals PCL
SET:APCO
|
Capital Expenditures
-฿975.1k
|
CAGR 3-Years
29%
|
CAGR 5-Years
18%
|
CAGR 10-Years
25%
|
|
|
D
|
Do Day Dream PCL
SET:DDD
|
Capital Expenditures
-฿24.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Thai Nippon Rubber Industry PCL
SET:TNR
|
Capital Expenditures
-฿143.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
I
|
Inter Pharma PCL
SET:IP
|
Capital Expenditures
-฿144.1m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
K
|
Karmarts PCL
SET:KAMART
|
Capital Expenditures
-฿234.8m
|
CAGR 3-Years
-83%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-25%
|
|
|
D
|
DOD Biotech PCL
SET:DOD
|
Capital Expenditures
-฿11.8m
|
CAGR 3-Years
57%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Asian Phytoceuticals PCL
Glance View
Asian Phytoceuticals Public Co., Ltd. engages in the research and development, manufacture, and distribution of health and beauty products from natural extracts. The company is headquartered in Lamphun, Lamphun. The company went IPO on 2011-11-04. The firm specializes in the manufacture of dietary supplements, cosmetics and personal care products developed from natural plant and botanical extracts. The firm offers products across various categories, including anti-wrinkle products, slimming products, and other health products. The Company’s slimming products are sold under Gold Shape brand. The firm's anti-wrinkle and anti-spots products are sold under brands, including Gold Figor, Garcinia and Asian Life. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
See Also
What is Asian Phytoceuticals PCL's Capital Expenditures?
Capital Expenditures
-975.1k
THB
Based on the financial report for Jun 30, 2024, Asian Phytoceuticals PCL's Capital Expenditures amounts to -975.1k THB.
What is Asian Phytoceuticals PCL's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
25%
Over the last year, the Capital Expenditures growth was 73%. The average annual Capital Expenditures growth rates for Asian Phytoceuticals PCL have been 29% over the past three years , 18% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
